
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14360663
[patent_doc_number] => 10301619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 15/469681
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 34
[patent_no_of_words] => 11323
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469681 | Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides | Mar 26, 2017 | Issued |
Array
(
[id] => 14407651
[patent_doc_number] => 20190169669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => PHEROMONAL RECEPTOR OF SPODOPTERA LITTORALIS AND IDENTIFICATION OF NATURAL LIGAND OF SAID RECEPTOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/087312
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087312 | PHEROMONAL RECEPTOR OF SPODOPTERA LITTORALIS AND IDENTIFICATION OF NATURAL LIGAND OF SAID RECEPTOR AND USES THEREOF | Mar 21, 2017 | Abandoned |
Array
(
[id] => 14159289
[patent_doc_number] => 20190106747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => DRUGS, PHARMACOGENOMICS AND BIOMARKERS FOR ACIVE LONGEVITY
[patent_app_type] => utility
[patent_app_number] => 16/087465
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087465 | DRUGS, PHARMACOGENOMICS AND BIOMARKERS FOR ACIVE LONGEVITY | Mar 20, 2017 | Abandoned |
Array
(
[id] => 17815665
[patent_doc_number] => 11421264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Thiol-containing cleave reagents and oxidative wash
[patent_app_type] => utility
[patent_app_number] => 15/457344
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 124
[patent_no_of_words] => 40875
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457344 | Thiol-containing cleave reagents and oxidative wash | Mar 12, 2017 | Issued |
Array
(
[id] => 11949786
[patent_doc_number] => 20170253938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'DIVIDING OF REPORTER PROTEINS BY DNA SEQUENCES AND ITS APPLICATION IN SITE SPECIFIC RECOMBINATION'
[patent_app_type] => utility
[patent_app_number] => 15/445799
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18389
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445799
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/445799 | Dividing of reporter proteins by DNA sequences and its application in site specific recombination | Feb 27, 2017 | Issued |
Array
(
[id] => 14504417
[patent_doc_number] => 20190195863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Embryonic Cell-Based Therapeutic Candidate Screening Systems, Models for Huntington's Disease and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/079755
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079755 | Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof | Feb 23, 2017 | Issued |
Array
(
[id] => 13873941
[patent_doc_number] => 20190033311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHOD TO MONITOR AND QUANTIFY INTERPHASE NUCLEAR ENVELOPE RUPTURE EVENTS
[patent_app_type] => utility
[patent_app_number] => 16/077744
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077744 | Method to monitor and quantify interphase nuclear envelope rupture events | Feb 16, 2017 | Issued |
Array
(
[id] => 17527888
[patent_doc_number] => 11300568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Methods for the diagnosis and treatment of gastrointestinal stromal tumors
[patent_app_type] => utility
[patent_app_number] => 16/077172
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 14824
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077172 | Methods for the diagnosis and treatment of gastrointestinal stromal tumors | Feb 9, 2017 | Issued |
Array
(
[id] => 14519471
[patent_doc_number] => 10336983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Method for increasing the specific production rate of eukaryotic cells
[patent_app_type] => utility
[patent_app_number] => 15/428279
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 9255
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428279
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428279 | Method for increasing the specific production rate of eukaryotic cells | Feb 8, 2017 | Issued |
Array
(
[id] => 11822217
[patent_doc_number] => 20170211155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'METHOD FOR PREDICTING RISK OF METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 15/424340
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17280
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424340
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424340 | METHOD FOR PREDICTING RISK OF METASTASIS | Feb 2, 2017 | Abandoned |
Array
(
[id] => 15178799
[patent_doc_number] => 20190359991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => Method for Producing Mutant Filamentous Fungi
[patent_app_type] => utility
[patent_app_number] => 16/074167
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074167 | Method for Producing Mutant Filamentous Fungi | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11757601
[patent_doc_number] => 20170204469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'REPORTER VECTOR FOR EVALUATING CHARACTERISTICS OF SUBJECT CELL, ASSAY KIT, PROCEDURE AND DEVICE'
[patent_app_type] => utility
[patent_app_number] => 15/410401
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12733
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410401 | REPORTER VECTOR FOR EVALUATING CHARACTERISTICS OF SUBJECT CELL, ASSAY KIT, PROCEDURE AND DEVICE | Jan 18, 2017 | Abandoned |
Array
(
[id] => 13296769
[patent_doc_number] => 20180199921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => Cell-Based Artificial Olfactory Detector
[patent_app_type] => utility
[patent_app_number] => 15/410405
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410405 | Cell-Based Artificial Olfactory Detector | Jan 18, 2017 | Abandoned |
Array
(
[id] => 11663845
[patent_doc_number] => 20170152563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'THERAPEUTIC AGENT FOR EMPHYSEMA AND COPD'
[patent_app_type] => utility
[patent_app_number] => 15/410165
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 38759
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410165 | Therapeutic agent for emphysema and COPD | Jan 18, 2017 | Issued |
Array
(
[id] => 15210407
[patent_doc_number] => 20190367890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => Cell Line for Producing Recombinant Glycoproteins with Di-Antennary N-Glycans, Methods Using the Same, and Recombinant Glycoproteins
[patent_app_type] => utility
[patent_app_number] => 16/077425
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077425 | Cell Line for Producing Recombinant Glycoproteins with Di-Antennary N-Glycans, Methods Using the Same, and Recombinant Glycoproteins | Jan 17, 2017 | Abandoned |
Array
(
[id] => 13873905
[patent_doc_number] => 20190033293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => NOVEL FUSIONS AND METHOD FOR DETECTING SAME
[patent_app_type] => utility
[patent_app_number] => 16/070110
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070110 | Fusions and method for detecting same | Jan 12, 2017 | Issued |
Array
(
[id] => 11744204
[patent_doc_number] => 20170198277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Compositions and Methods for Improving Homogeneity of DNA Generated Using a CRISPR/Cas9 Cleavage System'
[patent_app_type] => utility
[patent_app_number] => 15/402833
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19243
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15402833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/402833 | Compositions and methods for improving homogeneity of DNA generated using a CRISPR/Cas9 cleavage system | Jan 9, 2017 | Issued |
Array
(
[id] => 14182819
[patent_doc_number] => 20190111114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHODS FOR IDENTIFYING AND TREATING HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/067733
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067733 | METHODS FOR IDENTIFYING AND TREATING HEMOGLOBINOPATHIES | Dec 28, 2016 | Abandoned |
Array
(
[id] => 13622911
[patent_doc_number] => 20180363007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => A METHOD FOR REGENERATING T CELLS AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/520749
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520749
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/520749 | Method for regenerating T cells and applications thereof | Dec 27, 2016 | Issued |
Array
(
[id] => 13827181
[patent_doc_number] => 20190017075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
[patent_app_type] => utility
[patent_app_number] => 16/065756
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065756 | ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE | Dec 21, 2016 | Abandoned |